Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma
Clinical trial NCT01496807 · COMPLETED
Trial details
- NCT number
- NCT01496807
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-17
- Primary completion
- 2016-03-16
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.